Innovent Biologics, Inc. 信達生物製藥
Pay for financial year ended 2024-12-31
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Chen, Kaixian 陳凱先 | INED | 400 | 365 | 765 | |||
| 2 | Chen, Nick Shuyun 陳樹云 | INED | 267 | 172 | 439 | |||
| 3 | Cooney, Charles Leland | INED | 400 | 913 | 1,313 | |||
| 4 | Ede, Ronald Hao Xi 奚浩 | ED | 2,642 | 4,511 | 25,539 | 32,692 | ||
| 5 | Hsu, Joyce I Yin 許懿尹 | INED | 400 | 913 | 1,313 | |||
| 6 | Lu, Shun (1964) 陸舜 | INED | ||||||
| 7 | Yu, Michael De Chao 俞德超 | Ch, CEO, Pres | 2,897 | 37,702 | 95,173 | 135,772 | ||
| 8 | Zhang, Qian (1986) 張倩 | ED | 1,944 | 736 | 111 | 17,118 | 19,909 | |
| 9 | Zieziula, Gary | INED | 400 | 3,510 | 3,910 | |||
| Total | 1,867 | 7,483 | 42,949 | 111 | 143,703 | 196,113 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,867 | 7,483 | 42,949 | 111 | 143,703 | 196,113 | Report |
| 2023-12-31 | 1,600 | 5,489 | 38,058 | 0 | 126,180 | 171,327 | Report |
| 2022-12-31 | 1,433 | 5,384 | 34,536 | 0 | 130,025 | 171,378 | Report |
| 2021-12-31 | 1,122 | 5,119 | 26,500 | 0 | 116,707 | 149,448 | Report |
| 2020-12-31 | 1,122 | 5,241 | 18,994 | 0 | 94,155 | 119,512 | Report |
| 2019-12-31 | 1,482 | 5,241 | 15,540 | 165 | 63,644 | 86,072 | Report |
| 2018-12-31 | 761 | 4,201 | 90,765 | 142 | 16,996 | 112,865 | Report |
| Total | 9,387 | 38,158 | 267,342 | 418 | 691,410 | 1,006,715 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy